Salzman Group
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2200 Brighton Henrietta Town Line Rd, Ro...Phone Number
(585) 924-7170Website
www.salzmangrp.comRevenue
<$5 MillionIndustry
About Salzman Group
Salzman Group Org Chart
Is Salzman Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Salzman Group has new funding data
Product Launch: Get notified when Salzman Group launches new products
Website visits: Recent activity has been detected on your website
Check out if Salzman Group is spiking on competitors!
Click to see if Salzman Group had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Salzman Group
Earning: See what the market has to say on Salzman Group recently announced quarterly report
Salzman Group, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Salzman Group has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Salzman Group
Find more new buyers
Compare Similar Companies to Salzman Group
Compare insights from companies similar to Salzman Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Salzman Group is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Salzman Group is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Salzman Group.
Salzman Group Tech Stack
A closer look at the technologies used by Salzman Group
Salzman Group News & Media
Claritas Completes Acquisition of Exclusive Worldwide Rights to Develop and Commercialize R-107 for Pulmonary Disease
Data in Animal Model of PAH Demonstrate Ability of R-107 to Reverse Progression of the Disease Data in Animal Model of PAH Demonstrate Ability of R-107 to Reverse Progression of the DiseaseClaritas Announces Letter of Intent to Acquire Exclusive Worldwide Rights to Develop R-107 for PAH
Data in Animal Model of PAH Demonstrate Ability of R-107 to Durably Reverse Established DiseaseSAN FRANCISCO and TORONTO, April 14, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the "Company" or "Claritas") today announced that it has entered into a binding Letter of Intent (the “LOI”) with Salzman Group, Inc. (a Delaware corporation), Salzman Group, Ltd. (an Israeli corporation), and Salzman Group Pty. Ltd. (an Australian corporation), (collectivelyClaritas (formerly Kalytera Therapeutics, Inc.) to Collaborate with Salzman Group and Other Companies to Accelerate Development of R-107 for Treatment of Vaccine-Resistant COVID-19, Influenza, and Other Viral Infections
SAN FRANCISCO and TORONTO, March 03, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (formerly Kalytera Therapeutics, Inc.) (TSX VENTURE: KLY and OTC: KALTF) (the "Company" or "Claritas") today announced that it has entered into a Strategic Collaboration Agreement (the Collaboration Agreement”) with the Salzman Group, Ltd. (“Salzman Group”), and is in the process of entering into similar agreements with other companies, to expedite the development of the Company’s breakthrough nitric oxiKalytera Announces Exclusive License Agreement with Salzman Group for Development and Commercialization of R-107 for Treatment of Coronavirus and COVID-19 Infection
Exclusive License is Part of Larger Transaction to Acquire Salzman Group Exclusive License is Part of Larger Transaction to Acquire Salzman Group
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Salzman Group
We meet this objective by creating and developing our own drugs and those of others, serving both as an internal research engine and as a boutique contract service organization. For more than 25 years, the scientific team at Salzman Group has worked as a close-knit group, building a reputation for global leadership in basic science, drug developmen... Read More